News

  • Taiwan’s AI-driven clinical breakthroughs take centre stage at 2026 Taiwan Smart Medical & HealthTech Expo in Geneva

    The Taiwan Smart Medical & HealthTech Expo concluded yesterday at the Hotel President Wilson, showcasing how Taiwan is bridging the gap between theoretical Artificial Intelligence and real-world clinical application. Held on the sidelines of the 79th World Health Assembly (WHA), the event featured a "National Team" of 21 organisations and 9 premier medical centres, positioning [...]

  • Nourish secures US$100m funding

    Nourish has secured US$100m funding to scale its nutrition-first care platform for chronic disease and metabolic health. The Series C round brings the company’s total funding to US$215m and values it at US$1.75bn. Nourish combines registered dietitians with AI-powered care agents to tackle chronic disease and improve long-term outcomes. Co-founder Aidan Dewar said: [...]

  • Briya announced strategic partnership with InterSystems

    Briya and InterSystems have partnered on health AI to help researchers turn large healthcare datasets into evidence for research and patient care. The collaboration integrates Briya’s end-to-end AI research platform with InterSystems’ data connectivity infrastructure. The companies said the partnership is intended to help healthcare and life sciences organisations translate large volumes of raw data [...]

  • Boston Scientific CAD device shows promise in FRACTURE IDE trial

    Boston Scientific Corporation has announced positive results from the pivotal FRACTURE Investigational Device Exemption (IDE) trial evaluating the use of the SEISMIQ 4CE Coronary Intravascular Lithotripsy Catheter to treat patients with severely calcified coronary artery disease (CAD). The study met its primary safety and effectiveness endpoints, demonstrating high rates of freedom from major adverse cardiac [...]

  • NHS bill paves way for single patient record

    The NHS modernation bill, brought forward last week, would create a single patient record in England and cut bureaucracy, with ministers saying it would support safer and faster care. The single patient record would mean all NHS providers, including hospitals and GPs, would have to share data so the right doctors, nurses and specialists across [...]

  • UroMems secures US$60m investment from Ajax Health

    UroMems has raised US$60m from Ajax Health Fund I to support pivotal trials of its UroActive implant in the US and France ahead of regulatory submissions. The round is the company’s largest fundraising to date and comes less than a year after its US$47m Series C financing in June 2024. Co-founder Hamid Lamraoui [...]

  • Researchers train immune system to tackle drug-resistant infections

    Immune cells trained by scientists may help tackle resistant infections by boosting the body’s own defences instead of relying on new antibiotics. The approach is being explored as antimicrobial resistance, or AMR, continues to reduce the effectiveness of existing treatments. AMR happens when bacteria, viruses, fungi or parasites no longer respond to medicines, making infections [...]

  • Dr-Julian helps deliver breakthrough mental health support for Black and ethnically minoritised mothers

    A groundbreaking digital perinatal mental health pilot for Black and ethnically minoritised women has helped women access support faster, complete therapy at higher rates, and recover more successfully than national averages. The partnership between digital tech company Dr-Julian and The Essential Baby Company Ltd within a new model of mental health care named haPPIE SHE [...]

  • McDermott Will & Schulte advises Amulet Capital Partners on acquisition of TFP Fertility Group

    Global law firm McDermott Will & Schulte represented Amulet Capital Partners (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, in its acquisition of TFP Fertility Group, one of the leading fertility care providers in the UK and Northern Europe, from Benefit Street Partners (BSP) – a Franklin Templeton company. The [...]

  • Butterfly Medical secures US$21m to advance minimally invasive BPH treatment

    Butterfly Medical, developer of a proprietary non-surgical solution for BPH (benign prostatic hyperplasia), today announced the successful completion of its Series C funding round, raising US$21 million. The strong institutional demand validates the company’s therapeutic approach and competitive positioning. The round includes participation from new and existing investors, including the European Innovation Council (EIC), Junson [...]